TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Distance from the stent or CEJ to the buccal bone crest, mid-mesial root
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Ferriman-Gallwey scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieving desired implant position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Composite outcomes for CAL gain and LBG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative sensitivity of HPV testing for detection of CIN2+
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: FEV(1) increase compared to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Chest pain and symptoms of heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Exercise tolerance on treadmill exercise test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ED50, ED80, ED95 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Growth rate for self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Unplanned hospital days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: risk of dying or being hospitalized for a cardiac problem
Endpoint domain: Mortality/survival
Primary endpoint: Changes in VO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in VCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in MEE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Asthma prevalence among farmers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: mean augmentation to delivery interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-year stroke rate
Endpoint domain: Mortality/survival
Primary endpoint: 30-day death rate
Endpoint domain: Mortality/survival
Primary endpoint: composite endpoint of death, MI, or stroke
Endpoint domain: Mortality/survival
Primary endpoint: Need for oxygen supplementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: HRrest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PASIPD score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: distal femur aBMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: isokinetic torques of knee extensor and flexor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: CPAP failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total CPAP time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total oxygen time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: very-low-density lipoprotein-cholesterol (VLDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma serotonin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tetrofosmin uptake after nitrate administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sensitivity of tetrofosmin SPECT for detecting preserved metabolic activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Concordance between tetrofosmin SPECT and PET imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Extent of immediate paralysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 1-year patency rate
Endpoint domain: Mortality/survival
Primary endpoint: mean MTLD increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: free luminal area increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical health role limitations
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Body mass index percentile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum bactericidal antibody geometric mean titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total plasma GSH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in plasma viremia (HIV-1 RNA copies)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in CD4 cell counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: daily activity performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: percentage reduction of soluble IL-6 receptor levels (ng/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: augmentation index (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Written exam scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standardized patient exam performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluations of FT faculty
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: sustained visual improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: MMSE scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Duration of surgeries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Post-surgical complications
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of airway obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Psychotropic medication use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean increase in combined GHO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary nitrogen and sulfate values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Final error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting pressures at 24 months post-operatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urgency at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year incidence of atrial fibrillation (AF)
Endpoint domain: Mortality/survival
Primary endpoint: Survival from all-cause failure
Endpoint domain: Mortality/survival
Primary endpoint: 100 m freestyle swimming performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Xerostomia Questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: severe forms of malaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: anaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cardiorespiratory outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Temperature outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemoglobin A(1c) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: percent changes in Rrs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: FEV1.0 changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: physical composite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: log pHIV-RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean rate of decrease in pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of factor Xa activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Ganciclovir bioavailability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration (C(max)) of ganciclovir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to maximum concentration (T(max)) of ganciclovir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle strength improvement in leg press
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: muscle strength improvement in bench press
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: D-Dimer concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Detection of cervical intraepithelial neoplasia (CIN) grade 2 or worse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Detection of cervical intraepithelial neoplasia (CIN) grade 3 or worse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: learning and recall deficits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: positive, negative, and general schizophrenia symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: deficits in vigilance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Risk of PIH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: DSST score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: brain activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Claustrophobia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cerebrovascular reactivity to L‐A stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal flow rate (Qmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life after treatment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: freedom from target lesion failure (TLF)
Endpoint domain: Mortality/survival
Primary endpoint: Changes in mean PI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for denture material
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: GH area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Pain scores at rest and on coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total opioid requirement in the postoperative period
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Occurrence rate of diabetic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms of constipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Exercise intensity increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residual back and lower limb pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical outcome (excellent to good)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-efficacy improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complete response (loss of HBV-DNA and HBeAg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Seroconversion to anti-HBe
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Alanine aminotransferase levels normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: MSQ-role function-restrictive
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: MSQ-emotional functioning
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HIT-6 scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: downstaging rate (ypStage 0 to 1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in buprenorphine plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in medication adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in opioid withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom from atrial arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent atypical left atrial flutter (LAFL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in anxiety score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain/discomfort scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient overall tolerance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: adverse effect burden
Endpoint domain: Adverse events/effects
Primary endpoint: Total respiratory rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Sternocleidomastoid electromyogram activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pain distress scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insertion difficulty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance in 6MWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance in 6ETC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DBP in FWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: blood pressure decrease rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: intestinal permeability changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Development of LA/SHL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital stay days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: prevalence of postoperative leg-wound infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: persistent wheezing illness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: squat performance total repetition count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CK concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: phase angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluid administration volume
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average nightly CPAP use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective sleepiness
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: SF36 quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: OAB-related nocturnal micturitions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Severe OAB-related nocturnal micturitions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Treatment benefit and willingness to continue treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: average peak flow velocity (APV) in response to acetylcholine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: eNOS protein expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: eNOS Ser1177-phosphorylation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Infection resolution
Endpoint domain: Adverse events/effects
Primary endpoint: Spontaneous bacterial peritonitis resolution
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of unplanned ICU transfers
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Progression of atherosclerotic burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 5-year probability of overall survival
Endpoint domain: Mortality/survival
Primary endpoint: 5-year probability of disease-free survival
Endpoint domain: Mortality/survival
Primary endpoint: rate of excellent to good cosmetic result
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Kappa-value for agreement on early CT changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Bronchopulmonary Dysplasia (BPD) rates
Endpoint domain: Adverse events/effects
Primary endpoint: Mortality related to pulmonary hemorrhage
Endpoint domain: Mortality/survival
Primary endpoint: Arterial oxygenation (PO2 and O2 saturation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: outpatient treatment costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: non-ulcer dyspepsia sum score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete absence of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Invasive group B streptococcal disease incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean number of attempts for epidural catheter placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: NRS reduction at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ODI improvement at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients not requiring analgesics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: new or enlarging T(2)-weighted hyperintense lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: new T(1)-weighted hypointense lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Fecal cholesterol excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma lathosterol/cholesterol ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Referral rates to mental health services
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Delays in receiving treatment
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: soluble intercellular adhesion molecule-1 (sICAM-1) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: oxidative burst in neutrophils, monocytes, and eosinophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mobilization of adhesion molecule CD11b
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: transcapillary filtration of albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transcapillary transport of alpha 2- and beta-globulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: permeability of skin capillary vessels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: elevation of serum ALT level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: total bilirubin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: therapist-rated alliance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Operator equivalent dose at the thorax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ratings of perceived exertion
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: resting lactate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean number of rescue bursts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean forced expiratory volume in 1 second
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean number of enterococci
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of bowel movements >or=3 per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Likelihood of having sex without contraceptive method
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes